GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 70 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,327,087,000 | +18.9% | 350,465 | +4.2% | 0.00% | 0.0% |
| Q1 2020 | $1,957,866,000 | -43.7% | 336,403 | -13.2% | 0.00% | -50.0% |
| Q4 2019 | $3,478,037,000 | +3.1% | 387,741 | -0.7% | 0.00% | 0.0% |
| Q3 2019 | $3,372,477,000 | -24.9% | 390,559 | -3.1% | 0.00% | -33.3% |
| Q2 2019 | $4,492,283,000 | +22.7% | 403,257 | +46.5% | 0.00% | 0.0% |
| Q1 2019 | $3,660,093,000 | +9.9% | 275,195 | +27.7% | 0.00% | 0.0% |
| Q4 2018 | $3,330,649,000 | – | 215,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |